Enterprise Trust & Investment’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$4.75M Sell
37,063
-1,453
-4% -$190K 1.98% 13
2022
Q1
$5.28M Sell
38,516
-15
-0% -$1.99K 1.89% 12
2021
Q4
$5.43M Sell
38,531
-300
-0.8% -$39.8K 1.9% 11
2021
Q3
$4.94M Buy
38,831
+4,000
+11% +$529K 2% 11
2021
Q2
$4.39M Buy
34,831
+17,881
+105% +$2.19M 1.79% 13
2021
Q1
$1.98M Sell
16,950
-50
-0.3% -$5.77K 0.89% 34
2020
Q4
$1.98M Buy
17,000
+7,000
+70% +$764K 0.94% 31
2020
Q3
$1.05M Buy
+10,000
New +$1.05M 0.59% 41

Other funds holding XLV

Enterprise Trust & Investment's XLV Position: Q2 2022 in Review

Enterprise Trust & Investment reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 3.8% in Q2 2022, selling an estimated $190K and leaving 37,063 shares worth $4.75M. The position accounts for 1.98% of the portfolio, ranked #13.

Enterprise Trust & Investment first reported a position in XLV in Q3 2020 and has held it in 8 quarters since. The position peaked at $5.43M in Q4 2021. 1,463 funds tracked by Wall St. Rank hold XLV as of Q2 2022.

  • Enterprise Trust & Investment held 37,063 shares of State Street Health Care Select Sector SPDR ETF worth $4.75M as of Q2 2022.
  • Enterprise Trust & Investment sold 1,453 State Street Health Care Select Sector SPDR ETF shares in Q2 2022, an estimated $190K.
  • State Street Health Care Select Sector SPDR ETF made up 1.98% of Enterprise Trust & Investment's portfolio in Q2 2022, its #13 holding.
  • Enterprise Trust & Investment first reported a position in State Street Health Care Select Sector SPDR ETF in Q3 2020 and has held it in 8 quarters since.
  • Enterprise Trust & Investment's State Street Health Care Select Sector SPDR ETF position peaked at $5.43M in Q4 2021.
  • 1,463 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2022.

Based on Enterprise Trust & Investment's 13F filing for Q2 2022, filed 22 Jul 2022.